Material Weakness (worsened) — Sales tax control deficiency continues unresolved since Q2 2023; remediation language regressed from 'have obtained' to 'have begun obtaining' customer tax documentation.

NASDAQ: ISPC iSpecimen Inc. 10-Q

iSpecimen revenue collapses 85% to $156k as specimen volume, pricing both plunge; burns $4M cash

Filed May 18, 2026 · Period ending March 31, 2026 · Compared to 10-Q May 19, 2025 · ~2 min read

5 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade ISPC commission-free

Open an account, get a free stock.

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 1, 2026 3:39 PM